...
首页> 外文期刊>International Journal of Environmental Research and Public Health >Health Economic Assessment: Cost-Effectiveness Thresholds and Other Decision Criteria
【24h】

Health Economic Assessment: Cost-Effectiveness Thresholds and Other Decision Criteria

机译:卫生经济评估:成本效益阈值和其他决策标准

获取原文
           

摘要

An article published in this Journal argued that New Zealand does not apply a cost-effectiveness threshold because medicines are funded within a fixed budget and because cost-effectiveness is only one of nine criteria that inform decisions. This Comment has explained that, from a theoretical perspective, the cost-effectiveness threshold model is not inconsistent with these two arguments. The observed annual variation in incremental cost-effectiveness ratios in New Zealand may originate from yearly differences in new medicines that request reimbursement and in the budget size, and from the fact that decision makers take into account other decision criteria in addition to cost-effectiveness.
机译:在《华尔街日报》上发表的一篇文章认为,新西兰没有适用成本效益阈值,因为药品是在固定预算内提供资金的,并且成本效益只是决定决策的九个标准之一。该评论解释说,从理论上讲,成本效益阈值模型与这两个论点并不矛盾。在新西兰观察到的增量成本效益比率的年度变化可能源于要求报销的新药的年度差异和预算规模,以及决策者除了成本效益之外还考虑了其​​他决策标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号